Teva Pharmaceutical Industries Ltd. — Board/Management Information 2007

Sep 17, 2007

_________

C002��� ������ ��������� ��"�2PublicTEVA- PHARMACEUTICAL INDUSTRIES LTD.2529Corporation no: 520013954Stock Exchange/Market: ���310380P.O.B 3190 , Petach Tikva 49131 , ,Tel: 03-9267297 , 03-9267281 Fax: 03-9267429E.mail address: Liraz.Kalif@Teva.co.ilDate of transmission: 17/09/2007              Time of broadcast: 10:41 10:39:51

Reference: 2007-02-394978

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on Teva Announces Appointment of Isaac Abravanel as Corporate Vice President, Human Resources
newhrefinal160907_isa.pdf

Enclosed please find a PR issued on September16 , 2007 in Israel
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure: 05/09/2007
- - -
Name of the Signatory: : Suesskind Dan , , Position of Signatory in the reporting corporation: Chief Financial Officer
Basel Telephone: 02-5892840 , Facsimile: 02-5892839 , E-mail: dan.suesskind@teva.co.il